PHENYLBIGUANIDE manufacturers
- Phenylbiguanide
-
- $53.00 / 500mg
-
2025-04-27
- CAS:102-02-3
- Min. Order:
- Purity: 99.87%
- Supply Ability: 10g
- PHENYLBIGUANIDE
-
- $1.00 / 1KG
-
2020-03-05
- CAS:102-02-3
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 200kg
|
| | PHENYLBIGUANIDE Basic information |
| | PHENYLBIGUANIDE Chemical Properties |
| Melting point | 135-142 °C (lit.) | | Boiling point | 299.13°C (rough estimate) | | density | 1.2512 (rough estimate) | | refractive index | 1.6900 (estimate) | | storage temp. | Keep in dark place,Sealed in dry,Room Temperature | | solubility | alcohol: freely soluble | | pka | 10.76, 2.13(at 25℃) | | form | powder to crystal | | color | White to Orange to Green | | Merck | 14,7276 | | InChIKey | CUQCMXFWIMOWRP-UHFFFAOYSA-N | | CAS DataBase Reference | 102-02-3(CAS DataBase Reference) |
| WGK Germany | 3 | | RTECS | DU2450000 | | HS Code | 2925.29.6000 |
| | PHENYLBIGUANIDE Usage And Synthesis |
| Uses | 1-Phenylbiguanide is a 5-hydroxytryptamine receptor agonist. | | Definition | ChEBI: A member of the class of biguanides that is biguanide in which one of the terminal nitrogen atoms is substituted by a phenyl group. | | General Description | 1-Phenylbiguanide is a 5-hydroxytryptamine receptor agonist and increases extracellular dopamine release in rat nucleus accumbens in vivo. It serves as building block for synthesis of heterocyclic compounds. | | in vivo | In anaesthetised mice, Phenylbiguanide (PBG), a drug that is known to stimulate cardiopulmonary afferent C-fibres,is injected into the right atrium of the heart and mapped c-Fos expression within specific regions of the central nervous system. Intraatrial injection of PBG produces a reflex cardiorespiratory response including a pronounced bradycardia and a respiratory depression[3]. | | IC 50 | 5-HT3 Receptor: 3 μM (EC50) | | Purification Methods | Crystallise the biguanide from water or toluene. [Beilstein 12 H 370, 12 I 236, 12 III 807.] |
| | PHENYLBIGUANIDE Preparation Products And Raw materials |
|